Avoiding Inadequate Intrapartum Antibiotic Prophylaxis for Group B Streptococci

Area of Science:

• Obstetrics and Gynecology
• Neonatal Care
• Infectious Disease Prevention

Background:

• Group B streptococci (GBS) colonization in pregnant women poses a risk of neonatal infection.
• Intrapartum antibiotic prophylaxis is crucial for preventing early-onset GBS disease.
• Adherence to established guidelines, such as those from the Centers for Disease Control and Prevention (CDC), is vital for effective prophylaxis.

Purpose of the Study:

• To determine the incidence of inadequate GBS prophylaxis at an institution.
• To identify the primary reasons for inadequate GBS prophylaxis.
• To assess the proportion of GBS cases that could be prevented by perfect adherence to prophylaxis protocols.

Main Methods:

• Retrospective cohort study analyzing neonates born to GBS-colonized women.
• Maternal charts were reviewed to classify prophylaxis as adequate or inadequate.
• Cases were categorized as avoidable or unavoidable based on timing and eligibility for antibiotics according to 2010 CDC guidelines.

Main Results:

• 40.4% of neonates born to GBS-colonized women received inadequate prophylaxis.
• The majority of inadequate prophylaxis cases (79.7%) were unavoidable, even with perfect protocol adherence.
• Avoidable cases (20.3%) resulted from delayed antibiotic administration (72.5%) or incorrect antibiotic selection (27.5%).

Conclusions:

• A significant proportion of GBS prophylaxis was inadequate, though most cases were unavoidable.
• Improvements in timely antibiotic administration and appropriate antibiotic selection are needed.
• The overall impact of protocol adherence on GBS sepsis prevention may be modest.